To ask the Scottish Executive what advice has been issued to national health service boards regarding the prescribing of Herceptin. (S2O-9377)
Official Report · Chamber
Herceptin
SCOTTISH EXECUTIVE Health and Community Care
Speakers
Choose an MSP to read only their contributions- Margaret Jamieson Lab 2
- Lewis Macdonald Lab 2
The record
4 contributionsHerceptin is currently licensed for the management of HER2-positive breast cancer that has spread to other parts of the body. I understand that the manufacturer has applied for Herceptin also to be licensed for use in early-stage breast cancer. Decisions on whether to prescribe a treatment are made according to the clinical judgment of the doctor concerned, in consultation with and with the consent of the patient or carer, and bearing in mind the risks and benefits of treatment.
I advise the minister of a constituent inquiry that I received on 31 December. My constituent was advised by her consultant that she was suitable for treatment with Herceptin but the treatment was not financially approved by NHS Ayrshire and Arran. It was not until 25 January that NHS Ayrshire and Arran was advised that consensus has been reached throughout the national health service in the west of Scotland on the use of Herceptin and the funding for that. Does the minister agree that a clinician is the appropriate person to determine the treatment a patient receives and that finance should not be the only determining factor?
As I said in my initial answer, clinicians must certainly make a clinical judgment. However, it is important to recognise that they do so in the context of whether a treatment has been licensed, and Herceptin is licensed for treatment of HER2-positive breast cancer that has already spread and is not currently licensed for early-stage breast cancer, so the judgment that clinicians must make is clearly different. It is appropriate that any treatment goes through a proper process of assessment before being licensed for use in clinical circumstances.
In this meeting
Everything on 23 Mar 2006 →- Scottish Parliament Thursday 23 March 2006 Debate · 1
- Knowledge Economy Debate · 71
- SCOTTISH EXECUTIVE Questions · 1
- Scottish Compact Questions · 4
- Careers Scotland (Transfer of Responsibility) Questions · 8
- Antisocial Behaviour Orders (Glasgow) Questions · 4
- Planning etc (Scotland) Bill (Rights of Appeal) Questions · 6
- Air Travel (Islands) Questions · 9
- Local Authorities (Education Funding) Questions · 4
- Energy Efficiency Questions · 7
- Prime Minister (Meetings) First Minister’s Questions · 14
- Cabinet (Meetings) First Minister’s Questions · 16
- Smoking Ban (Enforcement) First Minister’s Questions · 6
- Honours (Recommendations) First Minister’s Questions · 6
- Scottish Water (Privatisation) First Minister’s Questions · 10
- Elderly People (Care) Questions · 18
- Partnership Agreement (Health) Questions · 4
- NHS Western Isles (Meetings) Questions · 6
- Herceptin Questions · 4
- National Health Service (Public Participation) Questions · 6
- Medical Centres Questions · 4
- Grocery Market (Inquiry) Questions · 8
- Scottish Water (Financial Strategy) Questions · 6
- Scottish Water (Chairman) Questions · 8
- Rural Postal Services Questions · 5
- Toxic Waste (Disposal Sites) Questions · 4
- Animal Cruelty Questions · 7
- Avian Flu (Contingency Planning) Questions · 4
- Environmental Courts Questions · 4
- Aging Population Strategy Debate · 33
- Decision Time Decision time · 29
- Hospital Closures (Coldstream and Jedburgh) Members’ business · 14
The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.